Cabot Corporation
$75.51
▲
0.85%
2026-04-21 05:55:00
www.cabotcorp.com
NYQ: CBT
Explore Cabot Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.94 B
Current Price
$75.51
52W High / Low
$83.71 / $58.33
Stock P/E
12.66
Book Value
$30.16
Dividend Yield
2.42%
ROCE
21.73%
ROE
21.82%
Face Value
—
EPS
$5.72
Exp Qtr EPS
—
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
4,064
Beta
0.83
Debt / Equity
65.12
Current Ratio
1.67
Quick Ratio
1.08
Forward P/E
10.88
Price / Sales
1.08
Enterprise Value
$4.95 B
EV / EBITDA
6.48
EV / Revenue
1.37
Rating
Hold
Target Price
$77.8
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Alto Ingredients, Inc. | $4.89 | 28.63 | $381.83 M | 0.33% | 4.61% | 5.67% | $5.25 / $0.77 | $3.17 |
| 2. | BioNexus Gene Lab Corp. | $2.28 | — | $5.32 M | — | -23.07% | -28.35% | $15.6 / $1.92 | $3.79 |
| 3. | 5E Advanced Materials, Inc. | $1.62 | — | $67.25 M | — | -68% | -1.2% | $7.5 / $1.17 | $2.19 |
| 4. | LyondellBasell Industries N.V. | $71.85 | — | $23.23 B | 4.02% | 2.98% | -6.95% | $83.94 / $41.58 | $31.3 |
| 5. | Northern Technologies International Corporation | $8.08 | — | $76.41 M | 0.49% | -7.58% | 0.36% | $10.03 / $6.75 | $7.63 |
| 6. | The Sherwin-Williams Company | $338.85 | 33.06 | $83.91 B | 0.93% | 20% | 59.39% | $379.65 / $301.58 | $18.67 |
| 7. | H.B. Fuller Company | $64.86 | 22.05 | $3.52 B | 1.51% | 8.51% | 8.32% | $68.63 / $48.71 | $37.91 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 849 M | 899 M | 923 M | 936 M | 955 M | — |
| Operating Profit | 129 M | 137 M | 167 M | 162 M | 155 M | — |
| Net Profit | 73 M | 43 M | 101 M | 94 M | 93 M | — |
| EPS in Rs | 1.4 | 0.82 | 1.93 | 1.8 | 1.78 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.71 B | 3.99 B | 3.93 B | 4.32 B |
| Operating Profit | 621 M | 614 M | 529 M | 572 M |
| Net Profit | 331 M | 380 M | 445 M | 209 M |
| EPS in Rs | 6.34 | 7.28 | 8.52 | 4 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.81 B | 3.74 B | 3.6 B | 3.52 B |
| Total Liabilities | 2.11 B | 2.15 B | 2.2 B | 2.49 B |
| Equity | 1.55 B | 1.43 B | 1.26 B | 898 M |
| Current Assets | 1.54 B | 1.6 B | 1.63 B | 1.82 B |
| Current Liabilities | 957 M | 772 M | 822 M | 1.1 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 665 M | 692 M | 595 M | 100 M |
| Investing CF | -298 M | -235 M | -214 M | -118 M |
| Financing CF | -336 M | -415 M | -403 M | 145 M |
| Free CF | 391 M | 451 M | 351 M | -111 M |
| Capex | -274 M | -241 M | -244 M | -211 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 1.6% | -9.03% | — | — |
| Earnings Growth % | -14.61% | 112.92% | — | — |
| Profit Margin % | 9.51% | 11.32% | 4.84% | — |
| Operating Margin % | 15.37% | 13.46% | 13.24% | — |
| Gross Margin % | 24.04% | 21.34% | 20.48% | — |
| EBITDA Margin % | 19.05% | 17.43% | 12.43% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-02-27 | $0.45 |
| 2025-11-28 | $0.45 |
| 2025-08-29 | $0.45 |
| 2025-05-30 | $0.45 |
| 2025-02-28 | $0.43 |
Stock Splits
No stock split history available.